Fig. 5.

Mean change in FPG and PPG concentrations from baseline at week-12 and -24 across the treatment groups. Data shown as least-squares mean (95% confidence interval); intergroup comparison p value; group 1, remogliflozin etabonate 100 mg; group 2, remogliflozin etabonate 250 mg; group 3, dapagliflozin 10 mg. Mean change in FPG concentration from baseline to week 12 and 24 of a PP and b mITT populations. Mean change in PPG concentration from baseline to week 12 and 24 of c PP and d mITT populations. FPG fasting plasma glucose, HbA1c glycated hemoglobin, mITT modified intent-to-treat, PP per protocol, PPG postprandial plasma glucose